Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
This step is crucial for maintaining sterility throughout the process
Despite their popularity, there remains a paucity of human clinical evidence to support their safety and efficacy
Nothing on this page constitutes medical advice, diagnosis, or treatment
During your consultation at Timeless Aesthetics, well assess your needs and recommend a treatment plan thats right for you
If a vial does accidentally freeze, it should be discarded, as freezing can degrade the peptide